These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4468550)

  • 1. [Inactivation of INH and effectiveness of chemotherapy in pulmonary tuberculosis].
    Gipp ZI
    Vrach Delo; 1974 Jan; (1):104-5. PubMed ID: 4468550
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of the phenotype of INH inactivation in pulmonary tuberculosis by means of an indirect method on the model of sulfamethazine].
    Powłowska I; Rakowska Z
    Pneumonol Pol; 1978 Aug; 46(8):605-12. PubMed ID: 714703
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effectiveness of the treatment of pulmonary tuberculosis with INAH preparations in different degrees of tubazid inactivation].
    Kagramanov AI; Ezerskiĭ VF; Ezerskaia EN; Kiroshka IZ; Grigorian VG
    Sov Med; 1973 Jul; 36(7):82-4. PubMed ID: 4776714
    [No Abstract]   [Full Text] [Related]  

  • 4. [Indicators of INH inactivation determined using a biological method and its use in monitoring antitubercular treatment].
    Czaplińska-Jóźwiak E; Szymański A; Dutkiewicz J
    Pneumonol Pol; 1986 Dec; 54(12):535-40. PubMed ID: 3588330
    [No Abstract]   [Full Text] [Related]  

  • 5. Levels of acetyl hydrazines and rate of acetylation of isoniazid in adult tuberculosis patients.
    Bhalerao EB; Bhide SV
    Indian J Physiol Pharmacol; 1985; 29(2):83-8. PubMed ID: 4093196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Resistance of Mycobacterium tuberculosis, the extent of isoniazid inactivation and blood bacteriostatic activity in chemotherapy of pulmonary tuberculosis].
    Tipp ZI
    Probl Tuberk; 1969; 47(8):76-9. PubMed ID: 4987468
    [No Abstract]   [Full Text] [Related]  

  • 7. [Initial resistance to streptomycin, isoniazid, rifampicin and ethambutol in bacillus-laden tuberculosis patients at the National Center of Pneumo-physiology at Cotonou (Benin)].
    Anagonou SY; Gninafon M; Josse R; Kinde-Gazard D; Tawo L; Foundohou J
    Bull Soc Pathol Exot; 1993; 86(2):144-7. PubMed ID: 8353477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of INH- and streptomycin-resistant patients].
    Böszörményi M; Schweiger O
    Z Tuberk Erkr Thoraxorg; 1965 Jul; 123(4):329-31. PubMed ID: 5897861
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical pharmacology of isoniazid].
    Sokolova GV; Ivleva AIa; Ziia AV; Zeliger LR; Suvorova VI
    Probl Tuberk; 1984 Sep; (9):55-60. PubMed ID: 6504886
    [No Abstract]   [Full Text] [Related]  

  • 10. [Significance of the isoniazid inactivation in the therapy of pulmonary tuberculosis].
    Gol'dshteĭn VD; Ioffe RA; Ponomareva ES
    Probl Tuberk; 1970; 48(1):34-9. PubMed ID: 5425443
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary resistance to major antituberculous drugs in patients with pulmonary tuberculosis in the years 1957-1964.
    Polończyk M
    Pol Med J; 1967; 6(3):604-9. PubMed ID: 6038083
    [No Abstract]   [Full Text] [Related]  

  • 12. Importance of acetylation and oxidation in inactivation of isonicotinic acid hydrazide preparations.
    Smirnov GA
    Fed Proc Transl Suppl; 1966; 25(1):72-6. PubMed ID: 5322111
    [No Abstract]   [Full Text] [Related]  

  • 13. Bacteriologic basis of short-course chemotherapy for tuberculosis.
    Grosset J
    Clin Chest Med; 1980 May; 1(2):231-41. PubMed ID: 6794976
    [No Abstract]   [Full Text] [Related]  

  • 14. [Inoculation of Mycobacterium tuberculosis and INH concentration in resected lung tissue].
    Vinnik LA; Sutyrina GV; Boldyreva AA; Shevchenko AM
    Probl Tuberk; 1965; 43(1):75-8. PubMed ID: 4953508
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of simultaneous administration of 5-bromosalicylhydroxamic acid (T40) and INH on the concentration of free INH in urine of tubercular patients].
    Zduńczyk-Pawelek H; Otrzonsek N; Kostrzewska K
    Z Tuberk Erkr Thoraxorg; 1965; 124(3):149-52. PubMed ID: 5899137
    [No Abstract]   [Full Text] [Related]  

  • 16. [Early results of non-effective chemotherapy with second-line drugs in pulmonary tuberculosis].
    Niemirowska H; Potworowska M
    Gruzlica; 1967 Dec; 35(12):1257-64. PubMed ID: 6079439
    [No Abstract]   [Full Text] [Related]  

  • 17. [The importance of the inactivation of phthivazid in the mechanism of resistance to it in Mycobacterium tuberculosis].
    Smirnov AG
    Ter Arkh; 1966 Aug; 38(8):28-32. PubMed ID: 6011765
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dynamics of drug resistance and restoration of sensitivity of Mycobacterium tuberculosis isolated from patients].
    Belogurova VP; Navrotskiĭ VV
    Antibiotiki; 1970 May; 15(5):434-7. PubMed ID: 4988018
    [No Abstract]   [Full Text] [Related]  

  • 19. Design and synthesis of antituberculars: preparation and evaluation against Mycobacterium tuberculosis of an isoniazid Schiff base.
    Hearn MJ; Cynamon MH
    J Antimicrob Chemother; 2004 Feb; 53(2):185-91. PubMed ID: 14688045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Errors in testing the INH content in the organism].
    Vilenskaia RN
    Probl Tuberk; 1970; 48(11):77-80. PubMed ID: 5516520
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.